SHALBY
|
|
BOM : 540797     NSE : SHALBY     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Nov 28,2023 |
Price(EOD): ₹ 320.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 3,463.56 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SHALBY | 1% | 23% | 121% |
APOLLO HOSPITALS ENTERPRISE | -1.8% | 11.1% | 17.3% |
MAX HEALTHCARE INSTITUTE | -0.5% | 6.4% | 41.7% |
FORTIS HEALTHCARE | 0.4% | 15% | 32.5% |
DR LAL PATHLABS | -2.4% | 11.9% | 10.1% |
NARAYANA HRUDAYALAYA | -0.6% | 22.9% | 64% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -1% | 1.4% | 29% |
ASTER DM HEALTHCARE | -1.5% | -0.1% | 48.1% |
RAINBOW CHILDRENS MEDICARE | -0.3% | -3.6% | 36.4% |
FUNDAMENTAL ANALYSIS OF SHALBY
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SHALBY
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
44.65
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 77.57 Cr
[Latest Qtr - Sep2023 - Consolidated Results ] 3.74
P/B Calculated based on Book Value of Rs 926.87 Cr
[Latest Year - Mar2023 - Consolidated Results ] 3.96
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 874.91 Cr
[Latest Qtr - Sep2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
153% 119% 56% |
SHARE PRICE MOMENTUM OF SHALBY
SHALBY vs SENSEX
DEBT OF SHALBY
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.05 0.05 0.08 0.06 |
0.18 0.05 0.08 0.1 |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SHALBY
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Sep2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SHALBY
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
1.06% 22.24% 29.32% 32.48% |
17.93% 42.18% 48.6% 49.86% |
QtrlyTrend |
8 | |
Latest Qtr: Sep2023 | ||
Quarterly Result Analysis → |
SHALBY related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | 0.9% | 7.3% | 15.3% |
S&P BSE MIDSMALLCAP | 0.6% | 10.1% | 36.2% |
S&P BSE HEALTHCARE | 0.2% | 9.9% | 26.9% |
S&P BSE SMALL CAP | 0.2% | 10% | 38.7% |
You may also like the below Video Courses
FAQ about SHALBY
Is SHALBY good for long term investment?
As on Nov 28,2023, the Fundamentals of SHALBY look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of SHALBY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SHALBY UnderValued or OverValued?
As on Nov 28,2023, SHALBY is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SHALBY ?
As on Nov 28,2023, the Intrinsic Value of SHALBY is Rs. 146.55 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 126.86
Fair Value [Median EV / Sales Model] : Rs. 146.55
Fair Value [Median Price / Sales Model] : Rs. 204.96
Estimated Median Fair Value of SHALBY : Rs. 146.55
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is SHALBY trading at a Premium or Discount?
As on Nov 28,2023, SHALBY is trading at a Premium of 119% based on the estimates of Median Intrinsic Value!